AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
KPTI vs KPEA Fundamental Comparison
| Metric | KPTI | KPEA |
|---|---|---|
| Revenue | $146.1M | $174,824.0 |
| Net Income | $-196.0M | $-265,577.0 |
| Net Margin | -134.2% | -151.9% |
| ROE | N/A | N/A |
| ROA | -180.8% | -26.4% |
| Current Ratio | 1.12x | 0.06x |
| Debt/Equity | N/A | N/A |
| EPS | $-17.93 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KPTI vs KPEA: Frequently Asked Questions
Is KPTI or KPEA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. KPTI is rated STRONG SELL (95% confidence) while KPEA is rated STRONG SELL (95% confidence). This is not investment advice.
How does KPTI compare to KPEA fundamentally?
Karyopharm Therapeutics Inc. has ROE of N/A vs Kun Peng International Ltd.'s N/A. Net margins are -134.2% vs -151.9% respectively.
Which stock pays higher dividends, KPTI or KPEA?
KPTI has a dividend yield of N/A or no dividend while KPEA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KPTI or KPEA for long term?
For long-term investing, consider that KPTI has STRONG SELL rating with 95% confidence, while KPEA has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KPTI vs KPEA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KPTI vs KPEA, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.